HOUSTON, June 14 — Manuel Neuer will start in goal for Germany against Curacao in his fifth World Cup, coach Julian Nagelsmann said on Saturday.
“All the players are fit and Manu will start,” Nagelsmann said at his pre-match press conference.
The game Sunday against the World Cup debutants will be the 40-year-old goalkeeper’s first appearance for Germany for nearly two years.
Neuer won the last of his 124 international caps in a Euro 2024 quarter-final defeat by Spain.
Nagelsmann brought him out of international retirement after he helped Bayern win the Bundesliga title and reach the Champions League semi-finals last season.
The 2014 World Cup-winner had to nurse a calf injury in the buildup to the 2026 tournament and played no part in the 4-0 friendly win against Finland and the 2-0 victory against the USA.
Neuer’s inclusion leaves Oliver Baumann, who has largely been Germany’s number one in the last two years, on the bench. — AFP
Turns out I’m two years behind on these so I’m getting ’em up! No commentary because I gotta run out the door to ink more pages of Seacritters, but hopefully I’ll come back to this down the line.
(Previously: 2023 in Reading, 2022 in Reading, 2021 in Reading, 2020 in Reading)
| Legend | Rough Guide to Ratings |
|---|---|
| 🎭 – Plays 📝 – Poetry 📖 – Books (Fiction) 📓 – Books (Nonfiction) 💬 – Graphic Novels 🔄 – Reread 🎙️ – Audiobook | ❤︎ = Yes ❤︎❤︎ = Oh Yes ❤︎❤︎❤︎ = Oh Hell Yes ❤︎❤︎❤︎❤︎❤︎ = Obviously this one hit at the right place and the right time |
RIO DE JANEIRO, June 9 — Brazil said yesterday it was temporarily suspending use of the world’s first single-dose dengue vaccine following two suspicious deaths.
More than half a million people have received doses of the vaccine this year, which was developed publicly in Brazil and approved by health authorities in November.
It is the first single-dose inoculation against the mosquito-borne dengue virus, which can cause high fever, headaches, muscle pain, nausea and rashes and in rare cases is fatal.
Of the 501,044 people vaccinated between January and May, 3,703 -- 0.7 percent—showed symptoms similar to dengue.
Forty-two people meanwhile had “more severe reactions,” according to the health ministry.
Authorities have recorded three severe cases, including two that resulted in the deaths of a 58-year-old man and a 48-year-old woman.
A 38-year-old woman entered intensive care but has since been discharged.
“There is not enough data to establish a cause-and-effect link between the vaccine and these three serious cases, but it is a warning signal,” Health Minister Alexandre Padilha told a press conference.
As a precaution, “we have decided to temporarily suspend vaccination,” he added, without elaborating on what would be required for it to be reintroduced.
The minister said the “absolutely unexpected” effects had not been observed during tests on over 16,000 volunteers across 14 Brazilian states.
Those trials had recorded an efficacy rate of 91.6 percent against the most severe form of the disease.
The only other dengue vaccine, TAK-003, requires two doses taken three months apart, according to the World Health Organization (WHO).
A single dose can help speed up and simplify mass vaccination campaigns.
Brazil recorded more than 6,000 dengue deaths in 2024 -- nearly half of recorded deaths worldwide—but the situation improved significantly last year. — AFP
Login